Healthcare

Singapore medical device output grew 4.2% in June

The industry outperformed the output of the manufacturing sector, which fell 6.9%.

Singapore medical device output grew 4.2% in June

The industry outperformed the output of the manufacturing sector, which fell 6.9%.

94% of Singapore firms attach international medical plans to healthcare programmes

This comes as employees seek more comprehensive plans to reduce out-of-pocket costs.

VC-sourced healthcare funding in Asia fell 39% to $2.57b in Q2

China-based Weimai’s $155m funding round was one of the quarter’s notable deals.

China healthtech funding crashed 49% to $1.92b in H1

The number of deals fell to 62 transactions in the same period.

India's healthtech deal value nearly doubled to $355m in H1

Investments in the wellness category ballooned to $155m.

Singapore clinched $145.78m of healthtech deals in 2018

The city trails only behind China and India in terms of deal value.

Asian healthtech deals hit $2.5b

$595m went to firms geared towards health management solutions.

The chatbot will see you now – virtual HCP engagement in the Asia Pacific

There is little doubt that the Asia Pacific region represents a key growth ambition for the majority of Life Sciences companies. Statistics around...

Cell therapy in the Asia Pacific — solution to the cancer challenge?

Over the next decade, an estimated $2t investment into Universal Health Coverage (UHC) schemes is expected to land in Asia. The developing markets in...

IT budgets could shrink for half of life sciences firms

Only 15% of life sciences firms believe digital tools could enhance customer experience.

Cheaper cell therapy gains ground in Australia, China, and Japan

In China, 80% of CAR-T trials are already being conducted by hospitals.

Migrant workers gain access to universal healthcare in Thailand

An estimated 1.5 million undocumented migrants registered with the Ministry of Public Health in 2018.

Top three healthcare firms in Singapore averaged total return at 31.2% in January-July 2019

These three firms’ average dividend yield came at 3.3% over the same period.

Indian drugmakers expand to China through joint ventures: report

Tight competition in the US is driving Indian pharmaceuticals east.

Buyout sought for India's Apollo Hospitals as owner seeks to pay debt

The aim is to reduce the Apollo shares pledged by the controlling family as collateral to lenders, to 20% of their total holding.

Taiwan's health ministry to greenlight cell therapies for two hospitals

Shin Kong International HealthCare Center in Taipei is likely to be approved for non-cancer related cell therapy.

Chinese healthcare revenue growth set to weaken

The plan by the State Council to cut high-value medical consumables prices deals a heavy blow.